Author name: Leonardo Arias

It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough programs on its hands.

A U.K. Court of Appeals ruling confirms the validity of a patent covering modifications of mRNA used in Moderna’s vaccines.

Wayne DeVeydt, a healthcare veteran who most recently worked at Bain Capital, will take up the finance chief job on Sept. 2 as the healthcare behemoth faces an array of operational challenges. 

The two countries will continue to negotiate over a 90-day period during which imports from Mexico will avoid a planned 30% tariff from the Trump administration. 

Cigna’s health insurance business is performing within expectations, even as the insurer faces persistently heightened medical costs, executives said.

In its first commercial quarter for ATTR-cardiomyopathy, Alnylam’s Amvuttra reached roughly 1,400 patients and made more than $490 million.

The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research into one entity.

Merck has characterized its cost-cutting initiative as more of a reallocation of resources to support other, higher-growth areas of its business.

Una nueva familia de péptidos terapéuticos ha demostrado efectos protectores frente a la enfermedad hepática grasa asociada a disfunción metabólica (MASLD, por sus siglas en inglés), una patología muy común que puede evolucionar hacia formas gr …

La miniaturización de dispositivos tecnológicos no cesa ni tampoco deja de sorprendernos. Ahora le ha tocado el turno a los espectrómetros, aparatos que descomponen la luz en sus distintas longitudes de onda o componentes y miden la intensidad de cada una, obteniendo en conjunto …